Fifty-five patients met study criteria. The majority of patients received venetoclax as first-line therapy (58%), with anti-CD20 antibody therapy (82%), and were at low risk of TLS (75%). No clinical ...
The field of oral biomaterials has witnessed significant innovation in recent years, particularly regarding the development ...
Purpose To investigate relevant patient-reported outcome (PRO) domains for oncology clinical practice. Methods We conducted cross-sectional semi-structured telephone interviews with patients with ...
The most successful physicians are not those who recall the most facts, but who couple facts with context and research to ...
Integrate current evidence-based interventions for MacTel into clinical practice to optimize disease outcomes. This activity ...
Understand the importance of training that saves lives. Providence uses simulations to ensure high-quality care through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback